0001125345-24-000063.txt : 20240308
0001125345-24-000063.hdr.sgml : 20240308
20240308161452
ACCESSION NUMBER: 0001125345-24-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peters Jeffrey Stuart
CENTRAL INDEX KEY: 0001706903
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 24734528
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wk-form4_1709932476.xml
FORM 4
X0508
4
2024-03-06
0
0001125345
MACROGENICS INC
MGNX
0001706903
Peters Jeffrey Stuart
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Senior VP and General Counsel
1
Common Stock
2024-03-06
4
M
0
10875
11.50
A
19770
D
Common Stock
2024-03-06
4
M
0
8750
10.15
A
28520
D
Common Stock
2024-03-06
4
S
0
19625
21.50
D
8895
D
Employee stock option (right to buy)
11.50
2024-03-06
4
M
0
10875
11.50
D
2030-02-20
Common Stock
10875
0
D
Employee stock option (right to buy)
10.15
2024-03-06
4
M
0
8750
10.15
D
2032-02-22
Common Stock
8750
39375
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.
12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
/s/ Lynn M. Cilinski, Attorney-in-fact
2024-03-08